A · Important
[Pathogen metagenomic detection reagents based on second-generation sequencing technology approved for marketing] On August 31, the State Food and Drug Administration disclosed that the State Food and Drug Administration recently approved the registration application for two pathogenic metagenomic detection reagents based on second-generation sequencing technology, namely the respiratory pathogen nucleic acid detection kit (combined probe-anchored polymerization sequencing method) of Guangzhou Weiyuan Medical Equipment Co., Ltd. and the bloodstream infection pathogen nucleic acid detection kit (reversible end termination sequencing method) of Tianjin Golden Key Medical Technology Co., Ltd.
Comments